Argenica Therapeutics Limited

AGN

Argenica Therapeutics Ltd. provides neuroprotective treatment. The company is headquartered in Nedlands, Western Australia. The company went IPO on 2021-06-11. The firm's lead neuroprotective peptide candidate, ARG-007, has been demonstrated to improve outcomes in pre-clinical stroke models, traumatic brain injury (TBI) and hypoxic ischemic encephalopathy (HIE). The firm has initiated a Phase 2 clinical trial in acute ischemic stroke patients, as well as continuing to generate preclinical data in other neurological conditions.

AGL Energy Limited.

AGL

AGL Energy Ltd. is an integrated renewable energy company, which engages in the provision of natural gas distribution services. The company is headquartered in Melbourne, Victoria. The company went IPO on 2006-10-12. The firm operates through three segments: Customer Markets, Integrated Energy, and Investments. The Customer Markets segment comprises the Consumer and Large Business customer portfolios responsible for the retailing of electricity, gas, telecommunications (broadband/ mobile/voice), solar and energy products and services to residential, small and large business customers. Its Integrated Energy segment operates a power generation portfolio and other key assets, including coal, gas and renewable generation facilities, natural gas storage and production facilities, and development projects. The Investments segment comprises the Company’s interests in the ActewAGL Retail Partnership, Tilt Renewables, Energy Impact Partners Europe, Solar Analytics Pty Limited, Sunverge Energy Inc, RayGen Resources Pty Ltd, Honey Insurance Pty Ltd and Ovo Energy Australia Pty Ltd.